OXYMIZER
Conserver, Oxygen
CHAD THERAPEUTICS, INC.
The following data is part of a premarket notification filed by Chad Therapeutics, Inc. with the FDA for Oxymizer.
Pre-market Notification Details
| Device ID | K830009 |
| 510k Number | K830009 |
| Device Name: | OXYMIZER |
| Classification | Conserver, Oxygen |
| Applicant | CHAD THERAPEUTICS, INC. 803 N. Front St. Suite 3 Mchenry, IL 60050 |
| Product Code | NFB |
| CFR Regulation Number | 868.5905 [🔎] |
| Decision | Substantially Equivalent (SESE) |
| Type | Traditional |
| 3rd Party Reviewed | No |
| Combination Product | No |
| Date Received | 1983-01-03 |
| Decision Date | 1983-04-02 |
NIH GUDID Devices
| Device Identifier | submissionNumber | Supplement |
|---|---|---|
| 10814470020126 | K830009 | 000 |
Trademark Results [OXYMIZER]
Mark Image Registration | Serial | Company Trademark Application Date |
|---|---|
 OXYMIZER 73445657 1324305 Live/Registered |
Chad Therapeutics, Inc. 1983-09-28 |
© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.